Changes of cardiovascular risk factors in obese children effects of inpatient and outpatient interventions

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 4, 2006, Pages 506-511

  Reinehr, Thomas ^a   De Sousa, Gideon ^a   Wabitsch, Martin ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Blood pressure; HDL cholesterol; Inpatient intervention program; Insulin; LDL cholesterol; Obesity; Outpatient intervention program; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; EXERCISE; FEMALE; HOSPITAL PATIENT; HUMAN; INSULIN BLOOD LEVEL; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT CARE; PRIORITY JOURNAL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; AMBULATORY CARE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; DIET THERAPY; EXERCISE THERAPY; HEALTH BEHAVIOR; HOSPITALIZATION; HUMANS; INSULIN; LIPIDS; OBESITY; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 33750012126     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000235752.29735.31     Document Type: Article

References (31)

1. Fisberg M, Baur L, Chen W, et al. Obesity in children and adolescents: working group report of the second world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr 2004;39:S678-87.
2. Ebbeling CA, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet 2002;360:473-82.
3. Jiang X, Srinivasan SR, Webber LS, et al. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med 1995;23:190-6.
4. Facchini FS, Hua N, Abbasi F, et al. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001;86:3574-8.
5. Reinehr T, Kiess W, deSousa G, et al. Intima-media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006;55:113-8.
6. Sung RYT, Yu CW, Chang SKY, et al. Effects of dietary intervention and strength training on blood lipid levels in obese children. Arch Dis Child 2002;86:407-10.
7. Knip M, Nuutinien O. Long-term effects of weight reduction on serum lipids and plasma insulin in obese children. Am J Clin Nutr 1993;57:490-3.
8. Wabitsch M, Hauner H, Heinze E, et al. Body-fat distribution and changes in atherogenic risk-factor profile in obese adolescent girls during weight loss. Am J Clin Nutr 1994;60:54-60.
9. Reinehr T, Kiess W, Kapellen T, et al. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004;114:1569-73.
10. Reinehr T, Andler W. Changes in the atherogenic risk-factor profile according to degree of weight loss. Arch Dis Child 2004;89:419-22.
11. Epstein LH, Kuller LH, Wing RR, et al. The effect of weight control on lipid changes in obese children. Am J Dis Child 1989;143:454-7.
12. Epstein LH, Roemmich JN, Raynor HA. Behavioral therapy in the treatment of pediatric obesity. Pediatr Clin North Am 2001; 48:981-93.
13. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity world-wide: international survey. BMJ 2000;320:1240-3.
14. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60.
15. Kromeyer-Hauschild K, Wabitsch M, Geller F, et al. Percentiles of body mass index in children and adolescents evaluated from different regional German studies. Monatsschr Kinderheilkd 2001;149:807-18.
16. Rosner B, Prineas RJ, Loggie JM, et al. Blood pressure normograms for children and adolescents by height, sex, and age, in the United States. J Pediatr 1993;123:871-86.
17. Reinehr T, Brylak K, Alexy U, et al. Predictors to success in outpatient training in obese children and adolescents. Int J Obes 2003;89:419-22.
18. Reinehr T, Kersting M, Alexy U, et al. Long-term follow-up of overweight children: after training, after a single consultation session and without treatment. J Pediatr Gastroenterol Nutr 2003;37:72-4.
19. Alexy U, Sichert-Hellert W, Kersting M, et al. The foods most consumed by German children and adolescents: results of the DONALD Study. Ann Nutr Metab 2001;45:128-34.
20. Kersting M, Sichert-Hellert W, Lausen B, et al. Energy intake of 1 to 18 year old German Children and adolescents. Z Ernährungswiss 1998;37:47-55.
21. Reinehr T, Kersting M, Wollenhaupt A, et al. Evaluation of the Training Program "OBELDICKS" for Obese Children and Adolescents. Klin Pädiatr 2005;217:1-8.
22. Rössner S, Björvell H. Early and late effects of weight loss on lipoprotein metabolism in severe obesity. Atherosclerosis 1987; 64:125-30.
23. Uusitupa MIJ, Laakso M, Sarlund H, et al. Effects of very-low-caloric diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 1990;51:768-73.
24. Reinehr T, Kersting M, Wollenhaupt A, et al. Nachweis der Effektivität des Adipositasprogramms "Obeldicks"- Gewichtsreduktion über bis zu 4 Jahre nach Behandlungsende und Verbesserung kardiovaskulärer Risikofaktoren-. Kinder- und Jugendmedizin 2005; 5:79-84.
25. Epstein LH, Paluch RA, Gordy CC, et al. Decreasing sedentary behaviours in treating pediatric obesity. Arch Pediatr Adolesc Med 2000;154:220-6.
26. De Jongh S, Ose L, Szamosi T, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 2002;106:2231-7.
27. Dirisamer A, Hachemian N, Bucek RA, et al. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation. Eur J Pediatr 2003;162:421-5.
28. Hanson L, Hedner T, Lindholm L, et al. The Captopril Prevention Project (CAPPP) in hypertension-baseline data and current status. Blood Press 1997;6:365-7.
29. Wang JG, Staessen JA. Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials. J Clin Hypertens 2003;5:66-75.
30. Brambilla P, Bedogni G, Moreno LA, et al. Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes Relat Metab Disord 2006;30:23-30.
31. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-34.